Abstract: Background: Renal transplant recipients are submitted to immunosuppression to avoid graft rejection, which makes them susceptible to various conditions. Furthermore, these individuals present malignant tumors more frequently than the general population, including nonmelanoma skin cancer. The individual genetic basis that acts in the pathogenesis of cutaneous cancer may present a protection or susceptibility factor for disease development. One of these factors is the HLA complex. oBjective: To investigate HLA alleles association to the occurrence of nonmelanoma skin cancer in renal transplant recipients from São Paulo State. Methods: A total of 213 patients (93 renal transplant recipients with nonmelanoma skin cancer and 120 renal transplant recipients without nonmelanoma skin cancer) were evaluated by retrospective and cross-sectional study. Epidemiological, clinical and HLA typing data were found in databases. HLA class I (A, B) and class II (DR) alleles were compared to establish their association with nonmelanoma skin cancer. results: Comparing renal transplant recipients with and without nonmelanoma skin cancer, the HLA-B*13 allele was associated with higher risk of developing nonmelanoma skin cancer while B*45 and B*50 alleles were associated with protection. study liMitations: The HLA A, B and DR alleles identification for the kidney transplantation routine is done by low and medium resolution techniques that do not allow discrimination of specific alleles. conclusion: The involvement of HLA alleles in nonmelanoma skin cancer in renal transplant recipients was confirmed in this study. Renal transplant recipients with HLA-B*13 showed higher risk for developing a skin cancer (OR= 7.29) and should be monitored for a long period of time after transplantation.
INTRODUCTION
Renal transplant recipients (RTR) are subject to iatrogenic immunosuppression to prevent graft rejection, what makes them susceptible to many diseases. Furthermore, these individuals develop malignant tumors more frequently when compared to the general population, including nonmelanoma skin cancers (NMSC). [1] [2] [3] [4] [5] [6] Multiple factors work together in promoting an increased risk for the development of skin cancer, among them the individual genetic basis, that can confer protection or susceptibility for the development of the condition. HLA complex (Human Leukocyte Antigen) is one of those determinants. 7, 8 The detection of susceptibility or protection alleles in RTRs allows the characterization of the risk profile for the development of NMSC. The identification of high risk patients will enable more effective preventative actions, such as change in habits (use of sunscreen and of sun protective clothing), routine dermatological consultations with the treatment of pre-malignant lesions and change 
of immunosuppression to mTOR inhibitors (mammalian target of rapamycin).

METHODS
Patients: a retrospective, cross-sectional study was conduct- Among the 120 RTRs without NMSC, 73 were male (60.8%). The mean age was 50 years, ranging from 23 to 72 years. The predominant phototype in the population analyzed was IV (39.2%), followed by III (28.3%). For most patients in this group, the etiology of the CKD was undetermined (46.7%). The etiologies identified were: hypertension in 12.5%; diabetes mellitus in 11.7%; chronic glomerulonephritis in 10.8%; polycystic kidney disease in 8.3%; urologic etiology in 3.3%; lupus nephritis in 3.3%; Alport syndrome in 1.7%;
and IgA nephropathy in 0.8%. Renal transplant was from a deceased donor in 65.0% of the patients. Treatment regime for post-transplant immunosuppression also varied. In this sample, most patients used three drugs, while 11 patients used two drugs (Table 1) .
HLA-A, B and DRB1* frequencies in RTRs with and without NMSC are shown in table 2. Table 3 (0.54% vs 3.64%, p=0.042, OR=0.14, 95%CI=0.02-1.14) were more frequent in the group of RTRs without NMSC, linking those alleles to a lower probability of developing NMSC.
The lower risk of developing NMSC was attributed to HLA-A*34 (0.0% vs 17.4%, p=0.021, OR=0.12, 95%CI=0.01-1.03) in
RTRs older than 50 years.
The analyses of the HLA alleles were also performed comparing skin phototypes and the presence of Bowen disease (intraepithelial SCC). No significant associations were found in these groups (data not shown).
Study limitations
HLA-A, B and DR alleles identified routinely in kidney and solid organ transplant use techniques of low and medium resolution that do not allow for the discrimination of specific alleles.
The limited number of patients included in this study is due to the availability of results in the files used for the research.
DISCUSSION
Squamous cell carcinoma is the most common non-melanoma skin cancer in renal transplant recipients, followed by basal cell carcinoma. Among the transplant recipients, the frequency of SCC exceeds that of BCC with a ratio of 3:1; in the general population this index is the opposite. [9] [10] [11] In the present study, we also observed a higher prevalence of SCC (85.0%), while 36.6% had SCC and BCC.
BCC was found on its own in only 15.1% of the sample. The association with the occurrence of viral warts was not high (47.3%) but there was a high association with actinic keratosis (80.6%).
NMSCs are more aggressive in solid organ transplant recipients (SOTRs); one of the factors for this aggressive behavior could be the presence of angiogenic factors that stimulate tumor growth.
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In recent years, many studies show a higher incidence of skin cancer
in RTRs, what could be explained by the increased survival of the patients, particularly due to the increased efficacy of immunosuppressive drugs. Exposure to multiple carcinogenic agents such as ultraviolet radiation (UVR) and HPV (human papillomavirus) infection is also responsible for the increase in the incidence of NMSC. 3, 11, 13, 14 Men are usually at a greater risk of developing NMSC, what was confirmed in our population, where 76.3% of patients were male. This could be attributed to many factors: men undergo renal transplants more frequently, have higher UVR exposure and are less prone to adhering to photoprotection. 3, 9, 15 In the present study, the predominant phototype in RTR with NMSC was II (45.2%), followed by III (25.8%), contrary to what is observed in the general immunocompetent population. 16, 17 Skin phototype I had a low prevalence (11.8%) and it might reflect the predominant skin phototype in the region of Brazil. The low prevalence (11.8%) of skin phototype IV was also observed, since these patients rarely develop NMSC. 15 The cause for kidney function loss was undetermined in the majority of cases. The most frequent causes were: hypertension, diabetes mellitus, chronic glomerulonephritis and polycystic kidney disease for both groups. The frequency of live donor was higher in RTR with NMSC (52.7%) but this was not statistically significant when compared to RTR without NMSC (35.0%).
Besides the factors already mentioned, other agents worked together promoting the increased risk of NMSC, including: individual genetic basis, age and sun exposure. 3, 6, 18, 19 The individual genetic basis that acts in the pathogenesis of skin cancer can be a protective or a susceptibility factor for the development of the disease. One of those determinants is HLA. 20 The structural and functional changes in the HLA molecule can reduce the expression of tumor antigens.
The absence of expression of co-stimulating molecules and the production of immunosuppressing cytokines are some of the possible mechanisms that help tumor cells escape immune surveillance, increasing the risk of developing tumor lesions such as cancer. 21 All donors and receptors are submitted to HLA typing before surgery or bone marrow transplant. The influence of HLA alleles on the outcome of the renal transplant is considerable, since when the compatibility between the recipient and the donor increases, the risk of rejection is minimized. 22 The mechanism by which the HLA system is involved in the development of NMSC is not yet entirely known. Some authors suggest the HLA alleles are associated to a higher or lower risk of skin cancer in solid organ transplant recipients (SOTR). In Brazil, HLA-DR1 appeared as a risk factor for NMSC, BCC in particular, even though this allele is not related to skin cancer in RTR in the European population. 8, 27 Recently, Cegielska et al showed that the HLA-DR15 allele is a susceptibility factor for NMSC, and that HLA-B18 is related to SCC. 26 HLA-A1 and HLA-A11 alleles were cited as protective factors for Bowen disease in Australian patients. 25 It was suggested that HLA-A11 is a protective allele for HPV-related cervical cancer. Bavinck et al showed that, in patients living in the Netherlands, HLA-A11 is a protective for skin cancer in general. 23 Surprisingly, when the same HLA-A11 was studied in Queensland, this allele was related to a higher occurrence of skin cancer. 24 The authors raised the hypothesis that UVR-induced photoantigens in Australian patients can compensate the risk factors induced by HPV infection in a more temperate climate. 24 It was demonstrated that HLA-B27 is a susceptibility factor for NMSC, particularly BCC. 23 Ingvar et al did not find any association between HLA typing and the risk for SCC in SOTRs. 28 In the immunocompetent population, the incidence of BCC was associated to HLA-DR1 and HLA-DR7, while HLA-DR4 was protective for the development of the disease, but there still are no solid evidences. Besides, HLA-A11 and HLA-B27 alleles are associated to the development of NMSC. 27, 29 The present study, conducted in a region with a tropical climate, with a historically mixed population, showed that the risk for developing NMSC among individuals undergoing a transplant was attributed to HLA-B*13, while the alleles HLA-B*45 and B*50 are associated to a lower probability of developing NMSC. The presence of HLA-A*34 was attributed to a lower risk for developing NMSC in RTRs older than 50 years of age. Epidemiological and clinical data did not show any correlation with HLA alleles.
CONCLUSION
The involvement of HLA alleles in the development of NMSC in RTRs was confirmed in this study, although with different alleles than those previously described in the literature. This fact can be attributed to the variation in the genetic background and geographical regions in which the studies were conducted, even in Brazil. However, the patients that have the HLA-B*13 allele require a long-term follow-up due to the higher probability (risk) of developing skin cancer after the transplant. q 
